Loading insider details...
Beta
Latest Form 4 (Feb 3, 2026): Sale of 555,555 AVBP shares, $12.98M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 3, 2026 | ArriVent BioPharma, Inc. (AVBP) | Sale | 555,555 | $12.98M |
| Dec 4, 2024 | BeiGene, Ltd. (BGNE) | Sale | 17,842,500 | $3.57B |
| Feb 1, 2024 | ArriVent Biopharma, Inc. (AVBP) | Conversion | 3,616,041 | n/a |
| Jun 15, 2023 | BeiGene, Ltd. (BGNE) | Sale | 611,000 | $129.20M |
| Jun 12, 2023 | BeiGene, Ltd. (BGNE) | Sale | 1,163,825 | $253.88M |
| Aug 24, 2022 | BeiGene, Ltd. (BGNE) | Other (see footnotes) | 7,800 | n/a |